欢迎访问新加坡聚知刊出版有限公司官方网站
info@juzhikan.asia
黑老虎(Kadsura coccinea)木脂素的保肝活性及其作用机制研究进展
  • ISSN:3029-2816(Online)3029-2808(Print)
  • DOI:10.69979/3029-2808.25.11.060
  • 出版频率:月刊
  • 语言:中文
  • 收录数据库:ISSN:https://portal.issn.org/ 中国知网:https://scholar.cnki.net/journal/search

黑老虎(Kadsura coccinea)木脂素的保肝活性及其作用机制研究进展
严文静

云南中医药大学云南省昆明市650500

摘要:肝脏疾病是全球性的重大公共卫生挑战,其发病率和死亡率居高不下,给社会带来沉重负担。从传统中药中发掘安全有效的保肝活性成分是当前新药研发的重要方向。黑老虎(Kadsura coccinea(Lem.)A.C.Sm.)作为五味子科(Schisandraceae)南五味子属的代表性植物,在我国民间有悠久的药用历史,常用于治疗多种炎性及损伤性疾病。现代植物化学研究表明,黑老虎富含木脂素类化合物,尤其是联苯环辛烯二烯类木脂素,是其发挥生物活性的主要物质基础。大量药理学研究证实,黑老虎木脂素表现出显著的保肝活性,能有效拮抗化学性、药物性、酒精性以及代谢性因素诱导的肝损伤。本文系统综述了近年来黑老虎木脂素在保肝活性方面的研究成果,深入阐述了其多途径、多靶点的作用机制,并对未来研究方向进行了展望,旨在为基于黑老虎木脂素的保肝新药或功能性食品的开发提供科学依据和理论参考。

关键词:黑老虎;Kadsuracoccinea;木脂素;肝脏保护;作用机制;综述

参考文献

[1]Ferlay J, Colombet M, Soerjomataram I, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 2021, 71(3):209-249.

[2]Wang Y, Liu J, Zhang L, et al. Traditional Chinese medicine for liver diseases: a review of current evidence and future prospects[J]. Journal of Ethnopharmacology, 2020, 259:112964.

[3] 国家中医药管理局《中华本草》编委会。中华本草(第 5 册)[M]. 上海:上海科学技术出版社,1999:345-347.

[4]Lin LZ, Liu JP. Lignans from Schisandraceae and their biological activities[J]. Natural Product Reports, 2009, 26(6):761-781.

[5]Yang S, Zhang H, Li X, et al. Chemical constituents and biological activities of Kadsura species: a review[J]. Chemistry & Biodiversity, 2018, 15(1):e1700444.

[6]Li Y, Wang H, Chen J, et al. New dibenzocyclooctadiene lignans from Kadsura coccinea[J]. Phytochemistry, 2016, 121:102-110.

[7]Zhang Q, Liu Y, Zhao L, et al. Kadcolignans A-J, new lignans from the stems of Kadsura coccinea[J]. Journal of Natural Products, 2017, 80(5):1432-1440.

[8]Chen S, Li J, Yang X, et al. Heilaohusuins A-E, new lignans from Kadsura coccinea and their hepatoprotective activities[J]. Fitoterapia, 2019, 135:104265.

[9]Wang L, Zhang Y, Liu S, et al. Hepatoprotective effects of Heilaohusuin B from Kadsura coccinea against acetaminophen-induced liver injury via activating Nrf2 pathway[J]. Biochemical and Biophysical Research Communications, 2020, 529(4):954-960.

[10]Jaeschke H, McGill MR, Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity[J]. Drug Metabolism Reviews, 2012, 44(2):88-106.

[11]Zhang H, Li S, Wang Y, et al. Antioxidant activity of phenolic compounds from Kadsura coccinea and their protective effects against H2O2-induced oxidative stress in HepG2 cells[J]. Food Chemistry, 2018, 240:791-798.

[12]Kobayashi M, Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against oxidative and electrophilic stress[J]. Current Opinion in Toxicology, 2018, 8:100-106.

[13]Kim HJ, Kim DH, Lee SK, et al. Anti-inflammatory effects of lignans from Schisandra chinensis through inhibition of NF-κB and MAPK pathways in LPS-stimulated RAW 264.7 cells[J]. International Immunopharmacology, 2011, 11(1):58-65.

[14]Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement[J]. The Lancet Gastroenterology & Hepatology, 2022, 7(1):19-34.

[15]Li M, Zhang J, Liu X, et al. Schisandrin C ameliorates non-alcoholic fatty liver disease in high-fat diet-induced obese mice by regulating lipid metabolism and inflammation[J]. Journal of Ethnopharmacology, 2020, 258:112902.

[16]Wang X, Li Y, Zhang H, et al. Lignans from Kadsura coccinea regulate lipid metabolism via SREBP-1c and AMPK signaling pathways in HepG2 cells[J]. Phytomedicine, 2019, 59:152978.

[17]Chen L, Wang J, Zhao Y, et al. In vitro evaluation of hepatoprotective and hypolipidemic activities of lignans from Kadsura coccinea[J]. Journal of Functional Foods, 2018, 47:386-394.

[18]Zhang L, Yang J, Xiao L, et al. Gut-liver axis: A new perspective for understanding non-alcoholic fatty liver disease[J]. Journal of Gastroenterology and Hepatology, 2019, 34(1):28-35.

[19]Huang Y, Chen S, Li J, et al. Kadsura coccinea lignans ameliorate liver injury in type 2 diabetic rats by regulating gut microbiota and improving intestinal barrier function[J]. Journal of Agricultural and Food Chemistry, 2021, 69(12):3612-3623.

[20]Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation[J]. Pharmacology & Therapeutics, 2013, 138(1):103-141.

[21]Liu Y, Zhang Q, Wang H, et al. Schisandrol B protects against diosgenin B-induced hepatotoxicity by inhibiting CYP3A4-mediated metabolism[J]. Toxicology Letters, 2018, 297:78-86.

[22]Chen J, Li Y, Yang S, et al. Synergistic hepatoprotective effects of Kadsura coccinea lignans and Chelidonium majus L. via reducing toxic metabolite formation[J]. Journal of Ethnopharmacology, 2020, 256:112768.

[23]Friedman SL, Bansal MB. Reversal of hepatic fibrosis—fact or fantasy?[J]. Hepatology, 2006, 43(2 Suppl 1):S82-S88.

[24]Yu C, Zhang H, Li X, et al. Schisandrol B induces apoptosis and inhibits proliferation of HepG2 cells through regulating PI3K/Akt/mTOR signaling pathway[J]. Oncology Letters, 2019, 18(3):2665-2672.

[25]Wang L, Liu S, Zhang Y, et al. Lignans from Kadsura coccinea inhibit hepatic stellate cell activation via TGF-β1/Smad pathway[J]. Phytomedicine, 2021, 88:153620.

[26]Zhang J, Li M, Wang X, et al. Structure-activity relationship of dibenzocyclooctadiene lignans from Schisandraceae as hepatoprotective agents[J]. European Journal of Medicinal Chemistry, 2020, 191:112212.

[27]Li Y, Chen J, Yang S, et al. Pharmacokinetics of major lignans from Kadsura coccinea in rats by UHPLC-MS/MS[J]. Biomedical Chromatography, 2019, 33(8):e4688.

[28]Sun X, Zhang H, Liu Y, et al. Nanoparticle-based delivery systems for lignans: A review[J]. Journal of Controlled Release, 2021, 334:408-423.

[29]Wang Y, Liu J, Zhang L, et al. Clinical evidence of traditional Chinese medicine for non-alcoholic fatty liver disease: A systematic review and meta-analysis[J]. Phytomedicine, 2020, 78:153398.

[30]Zhang Q, Li Y, Chen J, et al. Protocol for a randomized, double-blind, placebo-controlled trial of Kadsura coccinea lignans in patients with drug-induced liver injury[J]. Trials, 2021, 22(1):567.

[31]Yang S, Li X, Zhang H, et al. Cultivation techniques and quality evaluation of Kadsura coccinea: A review[J]. Industrial Crops and Products, 2020, 156:112884.